U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07146113) titled 'Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation' on June 26.
Brief Summary: A multicentre observational study on treatment approaches and biomarkers in de novo metastatic hormone sensitive prostate cancer in Russian Federation
Study Start Date: June 30
Study Type: OBSERVATIONAL
Condition:
Prostate Cancer
Recruitment Status: RECRUITING
Sponsor: AstraZeneca
Published by HT Digital Content Services with permission from Health Daily Digest....